The global demand for pain management devices is expected to grow at a healthy CAGR of 9% between 2022 and 2032, totaling a valuation of over US$ 5.68 Billion by the end of 2032, supported by,
| Data Points | Key Statistics |
|---|---|
| Pain Management Devices Market (2021) | US$ 2.2 Billion |
| Pain Management Devices Market Projected Size (2032) | US$ 5.68 Billion |
| Value CAGR from 2022 to 2032 | 9.0% |
The growing geriatric population will further boost the adoption of pain monitoring devices and will lead to an increase in the global pain management devices market. Pain management devices can manage and relieve various types of pain including neuropathic pain, cancer pain, and musculoskeletal pain. Manufacturers are continuously aiming at developing innovative pain management devices.
The increasing cases of diabetes, cancer, and mental disorders along with the increasing incidence of accidents will therefore continue to provide a strong thrust to the pain management device market growth during the forecast period. The increasing prevalence of chronic conditions and growing awareness among people regarding pain management devices and their advantage over opioids is set to propel the demand for pain management devices in the future years.
Centers for Disease Control and Prevention estimated 20.4% of USA adults (50.0 million) had chronic pain and 8.0% of USA adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age thereby boosting the demand for pain management devices globally. For instance, Boston Scientific introduced the WaveWriter Alpha™ Spinal Cord Stimulator System is the latest advancement in Chronic pain therapy. This therapy is designed to provide pain relief by sending mild electric pulses to the spinal cord to interrupt pain signals traveling to the brain.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The key driving forces for the pain management devices market in North America are a large pool of patients, increasing healthcare expenditure, and rising government funding and initiatives.
The growth of the market in the region is due to a rise in the aging population. Increase in the cancer population, increasing prevalence of lifestyle-associated disease, and increasing neuropathic disorders. In addition, increasing healthcare awareness and a rise in healthcare expenditure are also fuelling the growth of the global pain management devices market in North America. For instance, according to the Centre for Disease Control and Prevention, six in ten adults have a chronic disease.
Neurostimulation devices are mainly used to treat and relieve symptoms of neurological disorders including pain, epilepsy, tremor, stroke, etc. Also, neurostimulation devices are used for the treatment of various diseases associated with old age and neurotic ailments.
The rising incidence of neurological disorders, growing preferences for non-opioid treatments, and various benefits of neurostimulation devices boost the growth of the segment.
Boston Scientific also introduced a new therapy called Fast-Acting Sub-perception Therapy (FAST™). FAST is designed to allow patients to experience profound paresthesia-free pain relief in just minutes, delivering immediate and significant results to patients before they leave the clinic.
Over the years, pain management devices have gained immense traction across the world on account of their ability to manage and relieve various types of pain including neuropathic pain, cancer pain, and musculoskeletal pain. They have become ideal alternatives to pain management therapeutics like opioids due to their safe and effective nature.
Technological advancement in medical technologies is playing a crucial role in expanding the pain management devices market size. Manufacturers are continuously aiming at developing innovative pain management devices that can effectively improve the quality of life of patients.
Right from the management of chronic pain to relieving post-operating pain, patients with chronic diseases and traumatic injuries use various innovative pain management devices. The rapid surge in chronic conditions such as diabetes, cancer, and mental disorders along with the increasing incidence of accidents will therefore continue to provide a strong thrust to pain management device market growth during the forecast period.
Consequently, the rapid expansion of the pain monitoring devices market supported by a sharp rise in chronic pain cases is likely to create growth opportunities for pain management medical device companies in the future.
Principal Consultant
The global demand for pain management devices is slated to increase at a CAGR of 9% during the forecast period between 2022 and 2032. Growth in the market is driven by the rising prevalence of chronic conditions, growing awareness among people regarding pain management devices and their advantage over opioids, advancements in pain management devices, new product launches, and approvals. increase in the number of surgical procedures performed and expansion of chronic pain market size.
Pain management devices have become ideal solutions for managing and relieving acute and chronic pain triggered by cancer, migraine, musculoskeletal disorders, and several other chronic diseases. The introduction of these devices has significantly reduced the need for oral drugs, thereby allowing people to lead better life without developing any serious side effects.
The rise in the cases of chronic diseases such as cancer, diabetes, etc. worldwide will continue to provide a strong thrust to the growth of the global pain management devices market. As per the Cancer Research United Kingdom, globally there will be 27.5 million new cases of cancer each year by 2040.
The presence of these diseases triggers chronic pain that affects their life quality and work activities. As a result, people opt for pain management devices.
Similarly, growing concerns regarding drug addiction and the side effects of pain management therapeutics are encouraging people to adopt pain management devices. For instance, as per the National Survey on Drug Use and Health Report, around 10.1 million people aged 12 or older misused opioids in 2019.
The presence of reimbursement schemes for various pain management therapies, increasing investments in Research and Development activities, the growing popularity of wearable pain management devices, and various initiatives launched by governments will positively impact the pain management devices market growth during the forthcoming period.
What Factors are Restraining the Growth of the Pain Management Devices Market?
Some of the major factors restraining the pain management devices market growth are the high cost of pain management devices, hypersensitivity reactions and postoperative infections caused by the use of these devices, high consumption of pain management drugs as a first line of treatment, and poor availability of pain management devices in some low economic regions.
Increasing Incidence of Chronic Pain Driving Pain Management Devices Market in the USA
The USA pain management device market is poised to exhibit robust growth during the forecast period, owing to the easy availability of novel pain management devices, high level of health awareness among people, rising prevalence of chronic medical conditions like cancer, diabetes, spinal problems, etc., booming pain therapeutics solutions market, the surge in new product approvals, growing popularity of wearable medical devices, and presence of leading market players.
The rising prevalence of chronic pain is the major factor boosting the growth of the USA chronic pain market and pain management devices market. According to the Centers for Disease Control and Prevention (CDC), about 20.4% of adults had chronic pain in the United States in 2019. In order to manage and relieve this chronic pain people opt for innovative devices like implanted pain management devices.
Rising Adoption of Advanced Medical Devices Fueling Demand for Pain Management Devices in the United Kingdom
The latest pain management devices market trends indicate that demand for pain management devices across the United Kingdom is likely to grow at a healthy CAGR during the forecast period between 2022 and 2032.
This is attributable to the rising usage of technologically advanced medical devices like tens pain relief devices etc. due to their high effectiveness, the presence of some of the world's leading medical device manufacturers, increasing healthcare spending, and favorable government initiatives.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Demand for Neurostimulation Devices to Remain During the Forecast Period
Based on type, the global pain management devices market has been segmented into neurostimulation devices, infusion pumps, and ablation devices. Among these, neurostimulation devices segment dominated the global pain management devices market in 2021 and this pain management devices market trend is likely to continue during the assessment period.
The growth of this segment is attributable to the rising incidence of neurological disorders, growing preferences for non-opioid treatments, and various benefits of neurostimulation devices.
Neurostimulation devices are unique pain management products increasingly used by people to treat and relieve symptoms of neurological disorders including pain, epilepsy, tremor, stroke, etc. The rising adoption of these devices will significantly expand pain management devices market size during the forecast period.
Similarly, the expansion of the neurostimulation market will further create growth prospects for neurostimulation device manufacturers in the future.
Neuropathic Pain to Remain the Most Lucrative Application for Pain Management Devices Market
As per FMI, the neuropathic pain application segment will continue to dominate the global pain management devices market, accounting for the largest revenue share in 2022. Factors such as a rapid surge in traumatic injuries and chronic diseases, the increasing need for managing and relieving neuropathic pain, and the booming neuropathic pain market are driving the growth of this segment.
Besides this, advances in the acute pain market coupled with the expansion of the chronic pain market size are likely to favor the growth of this segment.
Leading pain management device manufacturers are investing in research and development to introduce novel pain management devices that can provide better relief to patients suffering from severe pain. Further, they are adopting growth strategies such as partnerships, new product launches and approvals, mergers, and acquisitions to expand their global footprint.
For instance:
Know and understand the prevailing pain management devices market trends with Future Market Insights' latest industry analysis and uncover hidden opportunities across various regional pockets.
The report follows a systematic approach to analyze key growth drivers augmenting pain management devices market growth. It illustrates how advancements in medical device technologies will transform the pain management devices market.
FMI also attempts to provide answers to queries like how will the rise in chronic diseases influence pain management device sales. What makes North America a global leader in pain management technologies And Which factors are pushing the demand for pain management devices across the Asia Pacific Detailed information on this is compiled in the global pain management devices market report, which is interspersed with relevant statistics and graphs.
Besides this, a certain number of chapters have been dedicated to analyzing the leading regional pockets and segments.
The Pain Management Devices Market analysis includes:
| Attributes | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historic Data Available for | 2015 to 2021 |
| Market Analysis | USD Million for Value |
| Report Coverage | Market forecast, company share analysis, competition intelligence, Drivers, Restraints, Opportunities and Threats analysis, market dynamics and challenges, and strategic growth initiatives |
| Key Segments Covered |
|
| Key regions covered | North America
|
| Application |
|
| Key companies profiled | Abbott Corporation (USA), Medtronic PLC (Ireland), Boston Scientific Corporation (USA), Stryker Corporation (USA), Becton, Dickinson and Company (USA), Baxter International (USA), Nipro Corporation (Japan), B. Braun Melsungen AG (Germany), Smiths Medical Corporation (USA), Moog Inc. (USA), Avanos Medical, Inc. (USA), Atricure Corporation (USA), Nevro Corporation (USA), and Micrel Medical Devices. |
| Customization & pricing | Available upon request |
The global pain management devices market reached around US$ 2.2 Bn in 2021.
As per FMI, pain management devices market is anticipated to grow at 9% CAGR throughout the forecast period totaling US$ 5.68 Bn by 2032.
North America is expected to remain the most lucrative market for pain management devices.
Medtronic PLC (Ireland), Boston Scientific Corporation (US), Abbott Corporation (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker Corporation (US), and Smiths Medical Corporation (US) are some of the leading manufacturers of pain management devices.
1. Executive Summary | Pain Management Devices Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Market, By Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in Optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Market Growth 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2015 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Type, 2015 to 2021 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2022 to 2032 8.3.1. Neurostimulation Devices 8.3.1.1. Transcutaneous Electrical Nerve Stimulation (Tens) Devices 8.3.1.2. Spinal Cord Stimulation 8.3.2. Infusion Pumps 8.3.2.1. High Use of Infusion Pumps 8.3.2.2. Intrathecal Infusion Pumps 8.3.2.3. External Infusion Pumps 8.3.3. Ablation Devices 8.3.3.1. RF Ablation Devices 8.3.3.2. Cryoablation Devices 8.4. Market Attractiveness Analysis By Type 9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2021 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032 9.3.1. Neuropathic Pain 9.3.2. Musculoskeletal Pain 9.3.3. Cancer Pain 9.3.4. Facial Pain & Migraine 9.3.5. Other Applications 9.4. Market Attractiveness Analysis By Application 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Mode of Purchase 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Mode of Purchase, 2015 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Mode of Purchase, 2022 to 2032 10.3.1. Prescription 10.3.2. Over-the-counter 10.4. Market Attractiveness Analysis By Mode of Purchase 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021 11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 12.4.1. By Country 12.4.1.1. USA 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Type 12.4.3. By Mode of Purchase 12.4.4. By Application 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Type 12.5.3. By Mode of Purchase 12.5.4. By Application 13. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Type 13.4.3. By Mode of Purchase 13.4.4. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type 13.5.3. By Mode of Purchase 13.5.4. By Application 14. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. United Kingdom 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Type 14.4.3. By Mode of Purchase 14.4.4. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type 14.5.3. By Mode of Purchase 14.5.4. By Application 15. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Type 15.4.3. By Mode of Purchase 15.4.4. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By Mode of Purchase 15.5.4. By Application 16. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Type 16.4.3. By Mode of Purchase 16.4.4. By Application 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Type 16.5.3. By Mode of Purchase 16.5.4. By Application 17. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. USA Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.2.2.1. By Type 17.2.2.2. By Mode of Purchase 17.2.2.3. By Application 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.3.2.1. By Type 17.3.2.2. By Mode of Purchase 17.3.2.3. By Application 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.4.2.1. By Type 17.4.2.2. By Mode of Purchase 17.4.2.3. By Application 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.5.2.1. By Type 17.5.2.2. By Mode of Purchase 17.5.2.3. By Application 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.6.2.1. By Type 17.6.2.2. By Mode of Purchase 17.6.2.3. By Application 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.7.2.1. By Type 17.7.2.2. By Mode of Purchase 17.7.2.3. By Application 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.8.2.1. By Type 17.8.2.2. By Mode of Purchase 17.8.2.3. By Application 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.9.2.1. By Type 17.9.2.2. By Mode of Purchase 17.9.2.3. By Application 17.10. United Kingdom Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.10.2.1. By Type 17.10.2.2. By Mode of Purchase 17.10.2.3. By Application 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.11.2.1. By Type 17.11.2.2. By Mode of Purchase 17.11.2.3. By Application 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.12.2.1. By Type 17.12.2.2. By Mode of Purchase 17.12.2.3. By Application 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.13.2.1. By Type 17.13.2.2. By Mode of Purchase 17.13.2.3. By Application 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.14.2.1. By Type 17.14.2.2. By Mode of Purchase 17.14.2.3. By Application 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.15.2.1. By Type 17.15.2.2. By Mode of Purchase 17.15.2.3. By Application 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.16.2.1. By Type 17.16.2.2. By Mode of Purchase 17.16.2.3. By Application 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.17.2.1. By Type 17.17.2.2. By Mode of Purchase 17.17.2.3. By Application 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional Footprint of Players 18.4.2. Product Footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Medtronic 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Abbott 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Boston Scientific 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Stryker 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Becton, Dickinson(BD) 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. B. Braun Melsungen AG 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. Baxter International 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. Avanos Medical, Inc. 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. Nipro Corporation 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. Micrel Medical Devices SA 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Pain Management Devices Market
